Raymond James Trust’s Mead Johnson Nutrition Company MJN Stock Holding History

Raymond James Trust’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-5,376	Closed	-$479K	–	748
2017 Q1	$479K	Buy	5,376 +249	+5%	+$20.5K	0.04%	381
2016 Q4	$363K	Buy	+5,127	New	+$382K	0.03%	442

Other funds holding MJN

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return

Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return

Envestnet Asset Management

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Raymond James Trust's MJN Position: Q2 2017 in Review

Raymond James Trust sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 5,376 shares — an estimated $479K sold.

Raymond James Trust first reported a position in MJN in Q4 2016 and held it in 2 quarters. The position peaked at $479K in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

Raymond James Trust reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
Raymond James Trust sold 5,376 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $479K.
Raymond James Trust first reported a position in Mead Johnson Nutrition Company in Q4 2016 and held it in 2 quarters.
Raymond James Trust's Mead Johnson Nutrition Company position peaked at $479K in Q1 2017.
7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Raymond James Trust's 13F filing for Q2 2017, filed 10 Aug 2017.